Muhammad Umair Mushtaq/X
Jun 15, 2025, 09:17
Muhammad Umair Mushtaq: Excited to Share that I’ve Been Selected as a Next Generation Scholar for the National Cancer Institute’s Blood and Marrow Transplant Clinical Trials Network
Muhammad Umair Mushtaq, Associate Professor Hematologic Malignancies & Cellular Therapeutics at KU Medical Center, shared a post on X:
“Excited to share that I’ve been selected as a Next Generation Scholar for the National Cancer Institute’s Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 2025-2026! Grateful for the opportunity and honored to contribute to this groundbreaking work in advancing cancer therapies.”
Stay updated with Hemostasis Today.
-
Aug 11, 2026, 11:38Maria Hadjidemetriou: The Patient Perspective in Thalassemia Care
-
Aug 11, 2026, 11:04Wolfgang Miesbach: The Critical Need for Tailored Dosing in VWD
-
Aug 11, 2026, 08:20Hasan Abbas Zaheer: Strengthening Universal Access to Safe Blood in Pakistan
-
Aug 11, 2026, 08:07Nicola Pozzi: Advancing Hemostasis Through Scientific Collaboration at Hemostasis GRC
-
Aug 11, 2026, 07:50When Access to Care Changes Everything – WFH
-
Aug 11, 2026, 07:41Kevin Land: How Cellular Therapy Is Changing Transfusion Medicine
-
Aug 11, 2026, 07:35Kuldeep Singh Bhadauria: Building the Future of Hemophilia Care in India
-
Aug 11, 2026, 07:28Archil Jaliashvili: When Every Minute Matters Time Becomes a Therapy
-
Aug 11, 2026, 07:05Mavis Agnes Kisakye: Building Sustainable Transition Pathways in Hemophilia Care